Literature DB >> 33711961

ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.

Hai Zhu1, Gang Wang2, Haixing Zhu3, Aman Xu4,5.   

Abstract

BACKGROUND: Integrin Subunit Alpha 5 (ITGA5), belongs to the integrin alpha chain family, is vital for promoting cancer cell invasion, metastasis. However, the correlation between ITGA5 expression and immune infiltration in gastrointestinal tumors remain unclear.
METHODS: The expression level of ITGA5 was detected by Oncomine and Tumor Immune Estimation Resource (TIMER). The association between ITGA5 and prognosis of patients was identified by Kaplan-Meier plotter, Gene Expression Profiling Interactive Analysis 2 (GEPIA2) and PrognoScan. We evaluated the correlation between ITGA5 expression and immune infiltrating level via TIMER. Besides, TIMER, immunohistochemistry (IHC) staining and western blot were used to explore correlations between ITGA5 expression and markers of immune infiltrates cells. Furthermore, we constructed protein-protein interaction (PPI) network and performed functional enrichment by GeneMANIA and Metascape.
RESULTS: ITGA5 was generally overexpressed and correlated with worse prognosis in multiple types of gastrointestinal tumors. In addition, ITGA5 expression level was significantly associated with tumor purity and immune infiltration levels of different immune cells in gastrointestinal tumors. Interestingly, immune markers for monocytes, tumor - associated macrophages (TAMs), macrophages 2 (M2) cells and T-helper 2 (Th2) cells were found to be significantly and positively correlated with ITGA5 expression levels in colon and gastric cancer. Results from IHC staining and western blot further proved that markers of Th2 and M2 cell were significantly increased in gastric cancer patients with high ITGA5 expression levels. Lastly, interaction network and function enrichment analysis revealed ITGA5 was mainly involved in "integrin mediated signaling pathway", "leukocyte migration", "cell-substrate adhesion". CONCLUTIONS: Our study demonstrated that ITGA5 may act as an essential regulator of tumor immune cell infiltration and a valuable prognostic biomarker in gastrointestinal tumors. Additional work is needed to fully elucidate the underlying mechanisms behind these observations.

Entities:  

Keywords:  Gastrointestinal tumor; ITGA5; Immune; Prognosis; Tumor-associated macrophages

Mesh:

Substances:

Year:  2021        PMID: 33711961      PMCID: PMC7953822          DOI: 10.1186/s12885-021-07996-1

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  48 in total

Review 1.  Regulation of the anti-tumour immune response by cancer-associated fibroblasts.

Authors:  James Harper; Richard C A Sainson
Journal:  Semin Cancer Biol       Date:  2014-01-07       Impact factor: 15.707

Review 2.  Macrophage polarity in cancer: A review.

Authors:  Masoud Najafi; Nasser Hashemi Goradel; Bagher Farhood; Eniseh Salehi; Maryam Shabani Nashtaei; Neda Khanlarkhani; Zahra Khezri; Jamal Majidpoor; Morteza Abouzaripour; Mohsen Habibi; Iraj Ragerdi Kashani; Keywan Mortezaee
Journal:  J Cell Biochem       Date:  2018-09-30       Impact factor: 4.429

3.  Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Authors:  Kenjiro Sawada; Anirban K Mitra; A Reza Radjabi; Vinay Bhaskar; Emily O Kistner; Maria Tretiakova; Sujatha Jagadeeswaran; Anthony Montag; Amy Becker; Hilary A Kenny; Marcus E Peter; Vanitha Ramakrishnan; S Diane Yamada; Ernst Lengyel
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

4.  E-M, an Engineered Endostatin with High ATPase Activity, Inhibits the Recruitment and Alternative Activation of Macrophages in Non-small Cell Lung Cancer.

Authors:  Min Xu; Shaosen Zhang; Lin Jia; Shan Wang; Jie Liu; Xuhui Ma; Chunying Wang; Yan Fu; Yongzhang Luo
Journal:  Front Pharmacol       Date:  2017-08-09       Impact factor: 5.810

5.  Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.

Authors:  Dariusz Waniczek; Zbigniew Lorenc; Mirosław Śnietura; Mariusz Wesecki; Agnieszka Kopec; Małgorzata Muc-Wierzgoń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-03-25       Impact factor: 4.291

6.  Proton irradiation orchestrates macrophage reprogramming through NFκB signaling.

Authors:  Géraldine Genard; Anne-Catherine Wera; Camille Huart; Benjamin Le Calve; Sébastien Penninckx; Antoine Fattaccioli; Tijani Tabarrant; Catherine Demazy; Noëlle Ninane; Anne-Catherine Heuskin; Stéphane Lucas; Carine Michiels
Journal:  Cell Death Dis       Date:  2018-06-27       Impact factor: 8.469

7.  The Prognosis Of Peroxiredoxin Family In Breast Cancer.

Authors:  Gang Wang; Wan-Chao Zhong; Yi-Hui Bi; Si-Yue Tao; Hai Zhu; Hai-Xing Zhu; A-Man Xu
Journal:  Cancer Manag Res       Date:  2019-11-14       Impact factor: 3.989

8.  PrognoScan: a new database for meta-analysis of the prognostic value of genes.

Authors:  Hideaki Mizuno; Kunio Kitada; Kenta Nakai; Akinori Sarai
Journal:  BMC Med Genomics       Date:  2009-04-24       Impact factor: 3.063

Review 9.  Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress.

Authors:  Zin W Myint; Gaurav Goel
Journal:  J Hematol Oncol       Date:  2017-04-24       Impact factor: 17.388

Review 10.  Tumor-associated macrophages: an accomplice in solid tumor progression.

Authors:  Yibing Chen; Yucen Song; Wei Du; Longlong Gong; Haocai Chang; Zhengzhi Zou
Journal:  J Biomed Sci       Date:  2019-10-20       Impact factor: 8.410

View more
  8 in total

1.  Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.

Authors:  Ridho Assidicky; Unal Metin Tokat; Ibrahim Oguzhan Tarman; Ozge Saatci; Pelin Gulizar Ersan; Umar Raza; Hasan Ogul; Yasser Riazalhosseini; Tolga Can; Ozgur Sahin
Journal:  Breast Cancer Res Treat       Date:  2022-03-25       Impact factor: 4.624

2.  DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines.

Authors:  Maria Urbanova; Verona Buocikova; Lenka Trnkova; Sabina Strapcova; Viera Horvathova Kajabova; Emma Barreto Melian; Maria Novisedlakova; Miroslav Tomas; Peter Dubovan; Julie Earl; Jozef Bizik; Eliska Svastova; Sona Ciernikova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

3.  AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer.

Authors:  Fanqi Wu; Longguo Zhang; Li Wang; Dekui Zhang
Journal:  Int J Gen Med       Date:  2022-02-22

Review 4.  Targeting Integrins for Cancer Therapy - Disappointments and Opportunities.

Authors:  Cecilia Bergonzini; Kim Kroese; Annelien J M Zweemer; Erik H J Danen
Journal:  Front Cell Dev Biol       Date:  2022-03-09

5.  ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas.

Authors:  Shuyu Li; Nan Zhang; Shiyang Liu; Hao Zhang; Jiajing Liu; Yiwei Qi; Qi Zhang; Xingrui Li
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

6.  Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.

Authors:  Hai Zhu; Wen Jiang; Haixing Zhu; Jinwei Hu; Bingge Tang; Zhiqiang Zhou; Xinyang He
Journal:  Int J Oncol       Date:  2022-03-22       Impact factor: 5.650

7.  Identification of Prognostic Genes in Gliomas Based on Increased Microenvironment Stiffness.

Authors:  Chaang-Ray Chen; Rong-Shing Chang; Chi-Shuo Chen
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

8.  Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density.

Authors:  Tessa A C M Vissers; Leonie Piek; Susana I S Patuleia; Aafke J Duinmeijer; Marije F Bakker; Elsken van der Wall; Paul J van Diest; Carla H van Gils; Cathy B Moelans
Journal:  Cancers (Basel)       Date:  2022-08-05       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.